Cargando…

Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk: A systematic review and meta-analysis

BACKGROUND: Genetic factors in the pathogenesis of cardiomyopathies have received a lot of attention during the past 2 decades. Some studies have reported that angiotensin-converting enzyme (ACE) gene has been associated with hypertrophic cardiomyopathy (HCM). However, there have been inconsonant re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ye, Meng, Lin, Zhou, Yan, Lu, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728739/ https://www.ncbi.nlm.nih.gov/pubmed/29310338 http://dx.doi.org/10.1097/MD.0000000000008639

Ejemplares similares

Angiotensin converting enzyme inhibitors and risk of lung cancer: A systematic review and meta-analysis
por: Batais, Mohammed, et al.
Publicado: (2021)

Safety and efficacy of angiotensin-converting enzyme inhibitors in aortic stenosis: A protocol for systematic review and meta-analysis
por: Xu, Chengsheng, et al.
Publicado: (2021)

The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy
por: Luo, Rong, et al.
Publicado: (2013)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Assessment of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker on the split renal function in the patients with primary hypertension
por: Zhang, Jingsi, et al.
Publicado: (2021)

Impact of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms on Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Risk
por: Yang, Jianmin, et al.
Publicado: (2013)

Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis
por: lv, Xiaodan, et al.
Publicado: (2018)

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Prognostic value of elevated plasma angiotensin-converting enzyme 2 in cardiometabolic diseases: A review
por: Zhou, Gang, et al.
Publicado: (2023)

Genetic polymorphism of methylenetetrahydrofolate reductase as a potential risk factor for congenital heart disease: A meta-analysis in Chinese pediatric population
por: Yuan, Ye, et al.
Publicado: (2017)

Influence of angiotensin-converting enzyme inhibition on reversibility of alterations in arterial wall and cognitive performance associated with early hypertension: A follow-up study
por: Csikai, Enikő, et al.
Publicado: (2019)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

Clinical significance of overweight in patients with hypertrophic cardiomyopathy: A retrospective cohort study
por: Chen, Ziwei, et al.
Publicado: (2021)

Roles of the crucial mitochondrial DNA in hypertrophic cardiomyopathy prognosis and diagnosis: A review
por: Liao, Xuewen, et al.
Publicado: (2023)

Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations
por: Guo, Xiying, et al.
Publicado: (2017)

Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy: A case report with RAF1 770C>T mutant
por: Wang, Xiaoqin, et al.
Publicado: (2016)

Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008)

Endomyocardial fibrosis and apical calcification: A case report with unusual presentations of apical hypertrophic cardiomyopathy
por: Gao, Man, et al.
Publicado: (2023)

Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy
por: Lai, Yongqiang, et al.
Publicado: (2017)

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy
por: Zhang, Xinlin, et al.
Publicado: (2017)

Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for systematic review and meta-analysis
por: Shi, Zhongping, et al.
Publicado: (2021)

A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report
por: Gao, Guangyuan, et al.
Publicado: (2020)

The efficacy and safety of traditional Chinese medicine treating diabetic cardiomyopathy: A protocol for systematic review and meta-analysis
por: Han, Shuo, et al.
Publicado: (2022)

Percutaneous left atrial appendage closure in patients with hypertrophic cardiomyopathy and persistent atrial fibrillation: 3-year-followed case series
por: Liu, Ying, et al.
Publicado: (2023)

Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis
por: Bian, Ru-tao, et al.
Publicado: (2021)

Effect of rs4646994 polymorphism of angiotensin-converting enzyme on the risk of nonischemic cardiomyopathy
por: Shen, Jinsheng, et al.
Publicado: (2021)

Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis
por: Wang, Guangqiang, et al.
Publicado: (2019)

Traditional Chinese medicine on treating dilated cardiomyopathy: A protocol for systematic review and meta analysis
por: Tan, Yuqing, et al.
Publicado: (2020)

Rs10757274 gene polymorphisms in coronary artery disease: A systematic review and a meta-analysis
por: Xu, Lang-Biao, et al.
Publicado: (2020)

Association analysis between ARG1 gene polymorphisms and idiopathic dilated cardiomyopathy
por: Shah, Syed Fawad Ali, et al.
Publicado: (2019)

The Associations Between the Polymorphisms of Vitamin D Receptor and Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Lu, Shuai, et al.
Publicado: (2016)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

A comprehensive evaluation of association between homocysteine levels and single nucleotide polymorphisms with hypertension risk: A protocol of systematic review and network meta-analysis
por: Kong, Yixuan, et al.
Publicado: (2020)

Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis
por: Wei, Meihao, et al.
Publicado: (2021)

Angiotensin converting enzyme polymorphism and ischemic stroke
por: Salem, Gelan M., et al.
Publicado: (2020)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

Angiotensin II Receptor Blockers and Cancer Risk: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Yun-Tao, et al.
Publicado: (2016)

The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies
por: Lei, Jinghui, et al.
Publicado: (2016)

The genetic polymorphisms of angiotensin converting enzyme insertion/deletion and glioma susceptibility: A meta-analysis
por: Sun, Meili, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8agnaa7d8esj08ocu2kv2fg6oa